Company: ATRA
Filing Date: 2025-05-23
Form Type: 3
Source: 0001104659-25-052410
Chunk: 1

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-05-23
Form: 3
Chunk 1
---
 |                                                                             |                                                        |                                                          |                                                       |

Remarks:

Mr. Nachi Subramanian is a managing director of Redmile Group, LLC ("Redmile"), and was appointed to the Issuer's board of directors as a representative of Redmile and its affiliates. As a result, each of Redmile and Jeremy Green, as principal of Redmile, is a director by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

| ** Signature of Reporting Person 
 /s/ By: /s/ Nachi Subramanian    | Date       
 05/23/2025 |

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. 
 Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.